Rap.ID

Berlin, Germany Founded: 2002 • Age: 24 yrs Acquired By Unchained Labs
Contract-based biopharmaceutical development and quality control services are provided.

About Rap.ID

Rap.ID is a Healthcare company based in Berlin (Germany) founded in 2002, and was acquired by Unchained Labs in March 2018. Contract-based biopharmaceutical development and quality control services are provided. Rap.ID offers products and services including Gaming Platform and Collaborative Games. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides.

Company details

Rap.ID was established in 2002 in Berlin, Germany, as a provider in the biopharmaceutical sector. Contract-based services are offered for drug development and quality control, supporting clients through specialized processes in formulation, testing, and regulatory compliance. Operations are centered in Europe, with a focus on efficient, scalable solutions for pharmaceutical partners seeking external expertise in product lifecycle management.

Key Metrics

Products & Services of Rap.ID

Rap.ID offers a comprehensive portfolio of products and services, including Gaming Platform and Collaborative Games.

Gaming Platform
Online Entertainment

Service for playing interactive games and earning cash prizes

Collaborative Games
Digital Content

Games developed through partnerships for competitive play

Funding Insights of Rap.ID

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Rap.ID with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2002Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Rap.ID

Rap.ID has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Unchained Labs and Freie Universitat Berlin.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
University offering multiple courses and degrees across diversified streams
1948fu-berlin.deBerlin, Germany
Multiplex protein stability platform for biologics is developed.
2015unchainedlabs.comPleasanton, United States
Premium access

Investor details for Rap.ID

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Rap.ID

3 dated milestones of Rap.ID across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Rap.ID is founded.
  2. Funding First funding round.
  3. Exit Acquired by Unchained Labs.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Rap.Id

Premium access

Complete news archive for Rap.ID

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rap.ID

Rap.ID was founded in 2002.

Rap.ID is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.

Rap.ID was established in 2002 in Berlin, Germany, as a provider in the biopharmaceutical sector. Contract-based services are offered for drug development and quality control, supporting clients through specialized processes in formulation, testing, and regulatory compliance. Operations are centered in Europe, with a focus on efficient, scalable solutions for pharmaceutical partners seeking external expertise in product lifecycle management.

Rap.ID offers Gaming Platform and Collaborative Games.

Rap.ID has 2 investors. Key investors include Unchained Labs, and Freie Universitat Berlin.

Yes. Rap.ID was acquired by Unchained Labs in March 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available